Lucid Diagnostics Inc (LUCD) Reports Q3, Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Lucid Diagnostics Inc (LUCD) PT Lowered to $3.80 at Cantor Fitzgerald
November 14, 2023 2:31 PM ESTCantor Fitzgerald analyst Ross Osborn lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $3.80 (from $4.00) while maintaining a Overweight rating.
The analyst comments "
Investment Summary. We reiterate our Overweight rating while we moderate our 12-month price target to $3.80 from $4.00 on Lucid... More
